Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.1264
+0.0082
+(6.94%)
At close: April 4 at 4:56:28 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Lars Öhman | Business Development Manager & Chairman | -- | -- | 1957 |
| Dr. Stefan K. Nilsson | Co-Founder & CEO | -- | -- | 1979 |
| Mr. Hugo Petit | Chief Financial Officer | -- | -- | 1970 |
Lipigon Pharmaceuticals AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 6
Description
Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden.
Corporate Governance
Lipigon Pharmaceuticals AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
STABL.ST Stayble Therapeutics AB (publ)
0.4480
-10.40%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
IMMU.ST Mendus AB (publ)
5.70
+2.46%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
ALZCUR.ST AlzeCure Pharma AB (publ)
2.6100
+9.66%